Use of Lecanemab for Patients With Cardiovascular Disease
Authors:
Open Access
- 2 April 2024
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 331 (13) , 1089-1090
Abstract
This Viewpoint discusses lecanemab use and the risk of cerebral macrohemorrhage for patients with mild cognitive impairment or early dementia.Keywords
This publication has 5 references indexed in Scilit:
- Donanemab in Early Symptomatic Alzheimer DiseaseJAMA, 2023
- Lecanemab: Appropriate Use RecommendationsThe Journal Of Prevention of Alzheimer's Disease, 2023
- Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for StrokeNew England Journal of Medicine, 2023
- Lecanemab in Early Alzheimer’s DiseaseNew England Journal of Medicine, 2023
- Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020JAMA Network Open, 2022